Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing

Transfusion

Volumn 50, Issue 7, 2010, Pages 1495-1504

  Zou, Shimian ^a,b   Dorsey, Kerri A ^a,b   Notari, Edward P ^a,b   Foster, Gregory A ^a,b   Krysztof, David E ^a,b   Musavi, Fatemeh ^a,b   Dodd, Roger Y ^a,b   Stramer, Susan L ^a,b  

^a HOLLAND LABORATORY   (United States)

^b AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD DONOR; CAUCASIAN; CHEMICAL ANALYSIS; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; MALE; NUCLEIC ACID TESTING; PREVALENCE; TREND STUDY; UNITED STATES;

ADOLESCENT; ADULT; AGED; BLOOD DONORS; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; RNA, VIRAL; UNITED STATES;

EID: 77954324675     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02622.x     Document Type: Article

References (24)

1. Stramer SL. US NAT yield: where are we after 2 years? Transfus Med 2002 12 : 243 53.
2. Dodd RY, Stramer SL, Aberle-Grasse J, Notari E. Risk of hepatitis and retroviral infections among blood donors and introduction of nucleic acid testing (NAT). Dev Biol (Basel) 2000 102 : 19 27.
3. Busch MP, Kleinman SH, Jackson B, Stramer SL, Hewlett I, Preston S. Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion 2000 40 : 143 59.
4. Stramer SL, Caglioti S, Strong DM. NAT of the United States and Canadian blood supply. Transfusion 2000 40 : 1165 8.
5. Dodd RY, Notari EP 4th., Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002 42 : 975 9.
6. Jackson BR, Busch MP, Stramer SL, AuBuchon JP. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003 43 : 721 9.
7. Stramer SL. Viral diagnostics in the arena of blood donor screening. Vox Sang 2004 87 Suppl 2 : 180 3.
8. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. NEJM 2004 351 : 760 8.
9. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH NHLBI-REDS NAT Study Group. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005 45 : 254 64.
10. Coste J, Reesink HW, Engelfriet CP, Laperche S, Brown S, Busch MP, Cuijpers HT, Elgin R, Ekermo B, Epstein JS, Flesland O, Heier HE, Henn G, Hernandez JM, Hewlett IK, Hyland C, Keller AJ, Krusius T, Levicnik-Stezina S, Levy G, Lin CK, Margaritis AR, Muylle L, Niederhauser C, Pastila S, Pillonel J, Pineau J, van der Poel CL, Politis C, Roth WK, Sauleda S, Seed CR, Sondag-Thull D, Stramer SL, Strong M, Vamvakas EC, Velati C, Vesga MA, Zanetti A. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang 2005 88 : 289 303.
11. Zou S, Notari EP, Fang CT, Stramer SL, Dodd RY. Current value of serologic test for syphilis as a surrogate marker for bloodborne viral infections among blood donors in the United States. Transfusion 2009 49 : 655 61.
12. Zou S, Stramer SL, Notari EP, Kuhns MC, Krysztof D, Musavi F, Fang CT, Dodd RY. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion 2009 49 : 1609 20.
13. Zou S, Fang CT, Dodd RY. A method for estimating incidence rate of infectious diseases among first-time blood donors. Transfusion 2008 48 : 1827 32.
14. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996 334 : 1685 90.
15. SAS Institute, Inc. SAS/STAT user's guide, version 6. 4th ed.
16. Stokes ME, Davis CS, Koch GG. Categorical data analysis using the SAS system. 2nd ed.
17. Brennan CA, Stramer SL, Holzmayer V, Yamaguchi J, Foster GA, Notari Iv EP, Schochetman G, Devare SG. Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors. Transfusion 2009 49 : 125 33.
18. Bernardin F, Stramer SL, Rehermann B, Page-Shafer K, Cooper S, Bangsberg DR, Hahn J, Tobler L, Busch M, Delwart E. High levels of subgenomic HCV plasma RNA in immunosilent infections. Virology 2007 365 : 446 56.
19. Zou S. Applying DALYs to the burden of infectious diseases [letter to the editor]. Bull World Health Organ 2001 79 : 267 9.
20. Delwart E, Stramer SL, Kamel H, Kessler D, Slikas B, Krysztof D, Carrick D, Todd D, Kakaiya R, Gotschall J, Busch M, for the Retrovirus Epidemiology Donor Study-II. Surveillance for divergent genotypes, drug-resistance and neutralization profiles in HCV, HBV and HIV infected donors. Transfusion 2008 48 : 251A 252A.
21. Orton SL, Stramer SL, Dodd RY, Alter MJ. Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV. Transfusion 2004 44 : 275 81.
22. Thompson ND, Perz JF, Moorman AC, Holmberg SD. Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Ann Intern Med 2009 150 : 33 9.
23. Delarocque-Astagneau E, Pillonel J, De Valk H, Perra A, Laperche S, Desenclos JC. An incident case-control study of modes of hepatitis C virus transmission in France. Ann Epidemiol 2007 17 : 755 62.
24. Centers for Disease Control and Prevention (CDC). Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopy clinic - Nevada, 2007. MMWR 2008 57 : 513 7.